Feasibility of percutaneous vagus nerve stimulation for the treatment of acute asthma exacerbations

Academic Emergency Medicine

Volumn 19, Issue 4, 2012, Pages 421-429

  Miner, James R ^a   Lewis, Lawrence M ^b   Mosnaim, Giselle S ^c,d   Varon, Joseph ^e   Theodoro, Daniel ^b   Hoffmann, Thomas J ^f  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e Dorrington Medical Associates   (United States)

^f ElectroCore LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IPRATROPIUM BROMIDE; MAGNESIUM SULFATE; SALBUTAMOL;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; DISEASE EXACERBATION; DYSPHAGIA; ELECTRODE; FEMALE; FORCED EXPIRATORY VOLUME; HEMATOMA; HUMAN; LUNG FUNCTION TEST; MALE; MUSCLE TWITCH; PRIORITY JOURNAL; SWALLOWING DIFFICULTY; TREATMENT FAILURE; VAGUS NERVE STIMULATION; VOICE CHANGE;

ACUTE DISEASE; ADULT; AGED; ASTHMA; EMERGENCY SERVICE, HOSPITAL; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SPIROMETRY; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; VITAL SIGNS; WORK OF BREATHING;

EID: 84859919444     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2012.01329.x     Document Type: Article

References (46)

1. American Lung Association Epidemiology and Statistics Unit. Trends in Asthma Morbidity and Mortality. Available at:. Accessed Jan 14, 2012.
2. Sepulveda P, Bohill G, Hoffmann TJ,. Treatment of asthmatic bronchoconstriction by percutaneous low voltage vagal nerve stimulation: case report. Internet J Asthma Allergy Immunol. 2009; 7: e1.
3. Green M, Widdicombe JG,. The effects of ventilation of dogs with different gas mixtures on airway calibre and lung mechanics. J Physiol. 1966; 186: 363-81.
4. Jammes Y, Mei N,. Assessment of the pulmonary origin of bronchoconstrictor vagal tone. J Physiol. 1979; 291: 305-16.
5. Maarsingh H, Leusink J, Bos IS, Zaagsma J, Meurs H,. Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res. 2006; 7: e6.
6. Mills JE, Widdicombe JG,. Role of the vagus nerves in anaphylaxis and histamine-induced bronchoconstrictions in guinea-pigs. Br J Pharmacol. 1970; 39: 724-31.
7. Richardson J, Beland J,. Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol. 1976; 41: 764-71.
8. Kanazawa H,. Increased responses to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection. Chest. 2004; 125: 1368-71.
9. Minette PA, Lammers JW, Dixon CM, McCuscker MT, Barnes PJ,. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol. 1989; 67: 2461-5.
10. Baker B, Peatfield AC, Richardson PS,. Nervous control of mucin secretion into human bronchi. J Physiol. 1985; 365: 297-305.
11. de Haas JR, Terpstra JS, van der Zwaag M, Kockelbergh PG, Roffel AF, Zaagsma J,. Facilitatory beta2-adrenoceptors on cholinergic and adrenergic nerve endings of the guinea pig trachea. Am J Physiol. 1999; 276 (3 Pt 1): L420-5.
12. Leff AR, Munoz NM, Hendrix SG,. Sympathetic inhibition of histamine-induced contraction of canine trachealis in vivo. J Appl Physiol. 1982; 53: 21-9.
13. Barnes PJ,. Neural mechanisms in asthma. Br Med Bull. 1992; 48: 149-68.
14. Mazzone SB, Canning BJ,. Evidence for differential reflex regulation of cholinergic and noncholinergic parasympathetic nerves innervating the airways. Am J Respir Crit Care Med. 2002; 165: 1076-83.
15. Venugopalan CS, Holmes EP, O'Malley NA,. Evidence for vasoactive intestinal peptide as a mediator of non-adrenergic non-cholinergic neurotransmission in the trachea. J Auton Pharmacol. 1990; 10: 297-304.
16. Venugopalan CS, Krautmann MJ, Holmes EP, Maher TJ,. Involvement of nitric oxide in the mediation of NANC inhibitory neurotransmission of guinea-pig trachea. J Auton Pharmacol. 1998; 18: 281-6.
17. Diamond L, O'Donnell M,. A nonadrenergic vagal inhibitory pathway to feline airways. Science. 1980; 208: 185-8.
18. Blaber LC, Fryer AD, Maclagan J,. Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle. Br J Pharmacol. 1985; 86: 723-8.
19. Hoffmann TJ, Mendez S, Staats P, Emala CW, Guo P,. Inhibition of histamine-induced bronchoconstriction in Guinea pig and Swine by pulsed electrical vagus nerve stimulation. Neuromodulation. 2009; 12: 261-9.
20. Simon BJ, Emala CW, Lewis LM, et al.,. Vagal nerve stimulation for relief of bronchoconstriction: preliminary clinical data and mechanism of action [abstract]. NANS 13th Annual Meeting, Las Vegas, NV, December 2009.
21. Bijl-Hofland ID, Cloosterman SG, Folgering HT, Akkermans RP, van den Hoogen H, van Schayck CP,. Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients. Eur Respir J. 1999; 13: 955-60.
22. Reddel HK, Taylor DR, Bateman ED, et al., An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180: 59-99.
23. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007; 120 (5 Suppl): S94-138.
24. Boudreaux ED, Emond SD, Clark S, Camargo CA Jr,. Acute asthma among adults presenting to the emergency department: the role of race/ethnicity and socioeconomic status. Chest. 2003; 124: 803-12.
25. Weber EJ, Silverman RA, Callaham ML, et al., A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med. 2002; 113: 371-8.
26. Okayama M, Yafuso N, Nogami H, et al., A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity. J Allergy Clin Immunol. 1987; 80: 291-9.
27. Bijwadia JS, Hoch RC, Dexter DD,. Identification and treatment of bronchoconstriction induced by a vagus nerve stimulator employed for management of seizure disorder. Chest. 2005; 127: 401-2.
28. Morris GL 3rd, Mueller WM,. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology. 1999; 53: 1731-5.
29. You SJ, Kang HC, Kim HD, et al., Vagus nerve stimulation in intractable childhood epilepsy: a Korean multicenter experience. J Korean Med Sci. 2007; 22: 442-5.
30. Rush AJ, Sackeim HA, Marangell LB, et al., Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2005; 58: 355-63.
31. Spuck S, Nowak G, Renneberg A, Tronnier V, Sperner J,. Right-sided vagus nerve stimulation in humans: an effective therapy? Epilepsy Res. 2008; 82: 232-4.
32. Thompson GW, Levett JM, Miller SM, et al., Bradycardia induced by intravascular versus direct stimulation of the vagus nerve. Ann Thorac Surg. 1998; 65: 637-42.
33. Fisher JT, Vincent SG, Gomeza J, Yamada M, Wess J,. Loss of vagally mediated bradycardia and bronchoconstriction in mice lacking M2 or M3 muscarinic acetylcholine receptors. FASEB J. 2004; 18: 711-3.
34. Jooste E, Zhang Y, Emala CW,. Neuromuscular blocking agents' differential bronchoconstrictive potential in Guinea pig airways. Anesthesiology. 2007; 106: 763-72.
35. Soutar CA, Carruthers M, Pickering CA,. Nocturnal asthma and urinary adrenaline and noradrenaline excretion. Thorax. 1977; 32: 677-83.
36. Andersson RG, Grundström N,. Innervation of airway smooth muscle. Efferent mechanisms. Pharmacol Ther. 1987; 32: 107-30.
37. Belvisi MG, Stretton CD, Yacoub M, Barnes PJ,. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol. 1992; 210: 221-2.
38. Ellis JL, Undem BJ,. Inhibition by L-NG-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airway. Am Rev Respir Dis. 1992; 146: 1543-7.
39. Schwartz S, Davies S, Juers JA,. Life-threatening cold and exercise-induced asthma potentiated by administration of propranolol. Chest. 1980; 78: 100-1.
40. Gerritsen J, Koeter GH, Vander Weele LT, Knol K,. Propranolol inhalation challenge in relation to histamine response in children with asthma. Thorax. 1988; 43: 451-5.
41. Ind PW, Dixon CM, Fuller RW, Barnes PJ,. Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am Rev Respir Dis. 1989; 139: 1390-4.
42. Vatrella A, Parrella R, Pelaia G, et al., Effects of non- bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine. Eur J Clin Pharmacol. 2001; 57: 99-104.
43. Boskabady MH, Saadatinejad M,. Airway responsiveness to beta-adrenergic agonist (salbutamol) in asthma. J Asthma. 2003; 40: 917-25.
44. Berkin KE, Inglis GC, Ball SG, Thomson NC,. Effect of low dose adrenaline and noradrenaline infusions on airway calibre in asthmatic patients. Clin Sci (Lond). 1986; 70: 347-52.
45. Knox AJ, Campos-Gongora H, Wisniewski A, MacDonald IA, Tattersfield AE,. Modification of bronchial reactivity by physiological concentrations of plasma epinephrine. J Appl Physiol. 1992; 73: 1004-7.
46. Piascik MT,. The Pharmacology of Adrenergic Receptors. Available at:. Accessed Jan 14, 2012.